New Vitalis Pharmacy LLC dba New Vitalis Pharmacy

FDA Regulatory Profile

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy appears in FDA public data with 3 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0944-2023, Class II) was initiated on July 13, 2023.

Summary

Total Recalls
3
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0944-2023Class IITestosterone Cypionate-Testosterone Propionate 180-20 mg/mL in cottonseed oil, Compounded Rx, For InJuly 13, 2023
D-0899-2021Class IITestosterone Cypionate Testosterone Propionate, 180mg/mL, 20mg/mL, 1 mL vial, Rx only, New Vitalis September 22, 2021
D-0523-2020Class IITestosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution, 10 mL per vOctober 1, 2019